"John Muir Health, Concord Medical Center is a 245-licensed bed hospital that serves Contra Costa and southern Solano counties. The medical center has long been recognized as a preeminent center for cancer care and cardiac care, including open heart surgery and interventional cardiology. Other areas of specialty include general surgery, orthopedic, and neurology programs. John Muir Health, Concord Medical Center is accredited by The Joint Commission (TJC), a national surveyor of quality patient care. For ongoing updates and information about COVID-19, including how to access care, please visit the John Muir Health website."

During the past decade, John Muir Medical Center-Concord Campus conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 56 clinical trials were completed, i.e. on average, 147.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 24 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Muir Medical Center-Concord Campus" #1 sponsor was "Radiation Therapy Oncology Group" with 42 trials, followed by "National Cancer Institute (NCI)" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Abbott Medical Devices" with 9 trials sponsored and "SWOG Cancer Research Network" with 9 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Muir Medical Center-Concord Campus" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "Radiation Therapy Oncology Group" with 6 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "John Muir Medical Center-Concord Campus" are "Lung Cancer" (11 trials), "Prostate Cancer" (10 trials), "Breast Cancer" (9 trials), "Head and Neck Cancer" (9 trials) and "Recurrent Ovarian Carcinoma" (9 trials). Many other conditions were trialed in "John Muir Medical Center-Concord Campus" in a lesser frequency.

Most popular intervention types in "John Muir Medical Center-Concord Campus" are "Drug" (95 trials), "Other" (68 trials), "Radiation" (54 trials), "Procedure" (40 trials) and "Biological" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "radiation therapy" (32 trials), "Quality-of-Life Assessment" (30 trials), "Paclitaxel" (20 trials) and "Questionnaire Administration" (16 trials). Other intervention names were less common.

The vast majority of trials in "John Muir Medical Center-Concord Campus" are 100 trials for "All" genders, 40 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "John Muir Medical Center-Concord Campus". undefined are not yet recruiting, 10 are recruiting, 34 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 91 completed trials in John Muir Medical Center-Concord Campus, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in John Muir Medical Center-Concord Campus, 8 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 20 trials that are defined as “Not Applicable".

John Muir Medical Center-Concord Campus has several departments that took part in Clinical trials: "John Muir/Mt. Diablo Comprehensive Cancer Center" - 30 trials, "Pacific Urology" - 2 trials